18 August 2022>: Articles
Post-COVID-19 Secondary Sclerosing Cholangitis: A Rare but Severe Condition with no Treatment Besides Liver Transplantation
Challenging differential diagnosis, Unusual setting of medical care, Rare disease
Marcel Cerqueira Cesar Machado A* , Roberto Kalil Filho E , Ibrahim Ahmad Hussein el Bacha B , Irai Santana de Oliveira C , Cristiane Maria de Freitas Ribeiro C , Heraldo Possolo de Souza D , Edison Roberto Parise CDOI: 10.12659/AJCR.936250
Am J Case Rep 2022; 23:e936250
Table 2. Laboratory tests during hospital evolution. Data obtained at hospital admission. Peak values and current data for these biochemical evaluations.
Admission | Peak | Current | |
---|---|---|---|
AST/ALT (IU/mL) | 132/92 | 139/32 | 54/5 |
GGT/ALP (IU/mL) | 625/294 | 2109/2031 | 568/786 |
Total bilirubin (mg/dL) | 1.89 | 21.72 | 14.22 |
Creatinine (mg/dL) | 4.03 | 4.03 | 1.677 |
C-Protein (mg/dL) | 23.95 | 23.95 | 13.67 |
ALP – alkaline phosphatase. |